Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEPITES: Viaskin Peanut in Peanut-allergic Children
NCT02636699Phase 3Completed
- Sponsor
- DBV Technologies
- Start
- Dec 2015
- Primary completion
- Aug 2017
- Modality
- Transdermal Patches
- Countries
- 5
01
Overview
A Phase 3 trial of peanut protein in peanut allergy, sponsored by DBV Technologies. Started Dec 2015; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT02636699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636699.